Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | mebeverine | 4031 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | mebeverine | 4031 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | mebeverine | 4031 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | mebeverine | 4031 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | mebeverine | 4031 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | mebeverine | 4031 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | mebeverine | 4031 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | mebeverine | 4031 | drug-path |
Asthma | R-HSA-444620 | map05310 | mebeverine | 4031 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | mebeverine | 4031 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | mebeverine | 4031 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | mebeverine | 4031 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | mebeverine | 4031 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | mebeverine | 4031 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | mebeverine | 4031 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | mebeverine | 4031 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | fendiline | 3336 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | fendiline | 3336 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | fendiline | 3336 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | fendiline | 3336 | drug-path |